Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil

References

• WhitefordHAFerrariAJDegenhardtLFeiginVVosTThe global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010PLoS One201510e011682025658103
   PubMed Web of Science ®Google Scholar
• GirardinFMembrane transporter proteins: a challenge for CNS drug developmentDialogues Clin Neurosci20068331132117117613
   PubMedGoogle Scholar
• MatsumotoJTakataFMachidaTTumor necrosis factor-α-stimulated brain pericytes possess a unique cytokine and chemokine release profile and enhance microglial activationNeurosci Lett201457813313824993300
   PubMed Web of Science ®Google Scholar
• UpadhyayRKDrug delivery systems, CNS protection, and the blood brain barrierBiomed Res Int2014201486926925136634
   PubMed Web of Science ®Google Scholar
• Garcia-GarciaEAndrieuxKGilSCouvreurPColloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?Int J Pharm2005298227429215896933
   PubMed Web of Science ®Google Scholar
• PatelMMGoyalBRBhadadaSVBhattJSAminAFGetting into the brainCNS Drugs2009231355819062774
   PubMed Web of Science ®Google Scholar
• ChenHChenCCAcostaCWuSYSunTKonofagouEEA new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug deliveryPLoS One2014910e10888025279463
   PubMed Web of Science ®Google Scholar
• MiyakeMMBleierBSThe blood-brain barrier and nasal drug delivery to the central nervous systemAm J Rhinol Allergy201529212412725785753
   PubMed Web of Science ®Google Scholar
• SousaFCastroPFontePSarmentoBHow to overcome the limitations of current insulin administration with new non-invasive delivery systemsTher Deliv201561839425565442
   PubMed Web of Science ®Google Scholar
• KlossekJMEfficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitisRev Laryngol Otol Rhinol (Bord)2007128318719218323331
   PubMedGoogle Scholar
• VyasTKShahiwalaAMaratheSMisraAIntranasal drug delivery for brain targetingCurr Drug Deliv20052216517516305417
   PubMedGoogle Scholar
• ChenJJiangHWuYLiYGaoYA novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluationDrug Des Devel Ther2015922652275
   PubMed Web of Science ®Google Scholar
• SpuchCNavarroCLiposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)J Drug Deliv2011201146967922203906
   PubMedGoogle Scholar
• LawSLHuangKJChouHYPreparation of desmopressin-containing liposomes for intranasal deliveryJ Control Release200170337538211182207
   PubMed Web of Science ®Google Scholar
• SamadASultanaYAqilMLiposomal drug delivery systems: an update reviewCurr Drug Deliv20074429730517979650
   PubMedGoogle Scholar
• ArumugamKSubramanianGMallayasamySAverineniRReddyMUdupaNA study of rivastigmine liposomes for delivery into the brain through intranasal routeActa Pharm200858328729719103565
   PubMed Web of Science ®Google Scholar
• MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm2009379114615719555750
   PubMed Web of Science ®Google Scholar
• HamblinKAWongJPBlanchardJDAtkinsHSThe potential of liposome-encapsulated ciprofloxacin as a tularemia therapyFront Cell Infect Microbiol201447924995163
   PubMed Web of Science ®Google Scholar
• AliJAliMBabootaSPotential of nanoparticulate drug delivery systems by intranasal administrationCurr Pharm Des201016141644165320210751
   PubMed Web of Science ®Google Scholar
• ZengSYeMQiuJPreparation and characterization of genipin-cross-linked silk fibroin/chitosan sustained-release microspheresDrug Des Devel Ther2015925012514
   PubMed Web of Science ®Google Scholar
• ZakiNMAwadGAMortadaNDElHadySSAEnhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport propertiesEur J Pharm Sci200732429630717920822
   PubMed Web of Science ®Google Scholar
• Al-AsmariAKUllahZAl-SabaanFTariqMAl-EidAAl-OmaniSFEffect of vitamin D on bioavailability and lipid lowering efficacy of simvastatinEur J Drug Metab Pharmacokinet2015401879424740652
   PubMed Web of Science ®Google Scholar
• WangXGuanQChenWHuXLiLNovel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluationDrug Des Devel Ther2015918051813
   PubMed Web of Science ®Google Scholar
• IllumLIs nose-to-brain transport of drugs in man a reality?J Pharm Pharmacol200456131714979996
   PubMed Web of Science ®Google Scholar
• MisraAGaneshSShahiwalaAShahSPDrug delivery to the central nervous system: a reviewJ Pharm Pharm Sci20036225227312935438
   PubMed Web of Science ®Google Scholar
• SongJMKirtaneARUpadhyayaPIntranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailabilityInt J Pharm20144771–29610125311179
   PubMedGoogle Scholar
• CoraceGAngeloniCMalagutiMMultifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochlorideJ Liposome Res201424432333524807822
   PubMed Web of Science ®Google Scholar
• van den BergMPVerhoefJCRomeijnSGMerkusFWUptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in ratsEur J Pharm Biopharm200458113113515207546
   PubMed Web of Science ®Google Scholar
• HaeriAAlinaghianBDaeihamedMDadashzadehSPreparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumorsIran J Pharm Res201413Suppl31424711824
   PubMedGoogle Scholar
• BhujbalSVde VosPNiclouSPDrug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumorsAdv Drug Deliv Rev201467–68142153
   PubMed Web of Science ®Google Scholar
• UngaroFd’AngeloIColettaCDry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymersJ Control Release2012157114915921864595
   PubMed Web of Science ®Google Scholar
• HeurtaultBSaulnierPPechBProustJEBenoitJPPhysicochemical stability of colloidal lipid particlesBiomaterials200324234283430012853260
   PubMed Web of Science ®Google Scholar
• Catalin BalaurePMihai GrumezescuASmart synthetic polymer nanocarriers for controlled and site-specific drug deliveryCurr Top Med Chem201515151424149025877097
   PubMed Web of Science ®Google Scholar
• NagayasuAUchiyamaKKiwadaHThe size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugsAdv Drug Deliv Rev1999401758710837781
   PubMed Web of Science ®Google Scholar
• FurubayashiTKamaguchiAKawaharadaKEvaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to ratsBiol Pharm Bull200730360861117329868
   PubMed Web of Science ®Google Scholar
• VarshosazJSadraiHHeidariANasal delivery of insulin using bioadhesive chitosan gelsDrug Delivery2006131313816401591
   PubMed Web of Science ®Google Scholar
• Ikechukwu UgwokeMKaufmannGVerbekeNKingetRIntranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systemsInt J Pharm20002021–212513110915935
   PubMedGoogle Scholar
• GraffCLPollackGMNasal drug administration: potential for targeted central nervous system deliveryJ Pharm Sci20059461187119515858850
   PubMed Web of Science ®Google Scholar
• DhuriaSVHansonLRFreyWH2ndIntranasal delivery to the central nervous system: mechanisms and experimental considerationsJ Pharm Sci20109941654167319877171
   PubMed Web of Science ®Google Scholar
• HashizumeROzawaTGryaznovSMNew therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163Neuro Oncol200810211212018287341
   PubMed Web of Science ®Google Scholar
• JoganiVVShahPJMishraPMishraAKMisraARIntranasal mucoadhesive microemulsion of tacrine to improve brain targetingAlzheimer Dis Assoc Disord200822211612418525282
   PubMed Web of Science ®Google Scholar
• JoganiVVShahPJMishraPMishraAKMisraARNose-to-brain delivery of tacrineJ Pharm Pharmacol20075991199120517883890
   PubMed Web of Science ®Google Scholar
• DoyleKPYangTLessovNSNasal administration of osteopontin peptide mimetics confers neuroprotection in strokeJ Cereb Blood Flow Metab20082861235124818364727
   PubMed Web of Science ®Google Scholar
• Martin-BanderasLHolgadoMAVeneroJLAlvarez-FuentesJFernandez-ArevaloMNanostructures for drug delivery to the brainCurr Med Chem201118345303532122087827
   PubMed Web of Science ®Google Scholar
• JainKKNanobiotechnology-based strategies for crossing the blood-brain barrierNanomedicine (Lond)2012781225123322931448
   PubMed Web of Science ®Google Scholar
• TosiGCostantinoLRuoziBForniFVandelliMAPolymeric nanoparticles for the drug delivery to the central nervous systemExpert Opin Drug Deliv20085215517418248316
   PubMed Web of Science ®Google Scholar